Babraham, United Kingdom

John Wahlich

This inventor holds 2 USPTO granted patents. Top assignee: Vhsquared Limited. Active years: 2020-2021.


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 2

Forward Citations = 16(Granted Patents)


Location History:

  • Cambridge, GB (2020)
  • Babraham, GB (2021)

Company Filing History:


Years Active: 2020-2021

Loading Chart...
2 patents (USPTO):Explore Patents

Title: John Wahlich: Innovator in Pharmaceutical Compositions

Introduction

John Wahlich is a notable inventor based in Babraham, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions for drug delivery. With a total of 2 patents to his name, Wahlich's work focuses on enhancing the effectiveness of pharmaceutical compositions.

Latest Patents

Wahlich's latest patents include a solid pharmaceutical composition designed for oral administration. This composition features a compressed core that contains a pharmaceutically active binding polypeptide. The core is coated with a pH-sensitive enteric coating, which allows for targeted delivery to specific regions of the intestinal tract. This innovative approach aims to improve the bioavailability and therapeutic efficacy of the active ingredients.

Career Highlights

Throughout his career, Wahlich has demonstrated a commitment to advancing pharmaceutical science. His work has been instrumental in developing formulations that enhance drug delivery systems. By focusing on the interaction between pharmaceutical compounds and the gastrointestinal environment, he has contributed to the creation of more effective treatment options.

Collaborations

Wahlich has collaborated with several professionals in the field, including Scott Crowe and Mike West. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

In summary, John Wahlich is a distinguished inventor whose work in pharmaceutical compositions has the potential to significantly impact drug delivery systems. His innovative approaches and collaborations highlight his dedication to improving healthcare solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…